Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Joint Tendering Creates ‘Attractive Nordic Market’

But Initiative Shows Supply Challenges Remain For Small Markets

Executive Summary

Joint tendering among Nordic countries can help reduce shortages of older, off-patent medicines. 

You may also be interested in...



Nordic Countries To Agree Closer Collaboration On Joint Price Negotiation And Procurement

Five Nordic countries are agreeing a common strategy for closer collaboration on access to hospital drugs.

European Cross-Country Pricing Collaborations Gather More Steam

Iceland has joined the Denmark-Norway pricing alliance while Denmark could soon join the BeNeLuxAI collaboration.

Nordic Procurement Deal Signals New Weapons In Fight For Lower Prices

A new joint procurement agreement between Norway and Denmark is a signal to drug companies that they will have to increasingly negotiate with more than one country in a new age of collaboration, says Amgros, the Danish medicines procurement agency.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS141718

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel